| 0 |
MEDIASTINAL INFECTION |
1 |
0.5000 |
| 1 |
VITAMIN C ABNORMAL |
1 |
0.1111 |
| 2 |
CONTRACEPTION |
1 |
0.0370 |
| 3 |
BRONCHIAL HYPERACTIVITY |
1 |
0.0227 |
| 4 |
NUCLEATED RED CELLS |
1 |
0.0089 |
| 5 |
GENITAL INJURY |
1 |
0.0075 |
| 6 |
CSF CELL COUNT INCREASED |
1 |
0.0068 |
| 7 |
ENTEROBACTER PNEUMONIA |
1 |
0.0064 |
| 8 |
UROBILINOGEN URINE INCREASED |
1 |
0.0061 |
| 9 |
BORDERLINE GLAUCOMA |
1 |
0.0054 |
| 10 |
EOSINOPHIL PERCENTAGE DECREASED |
1 |
0.0050 |
| 11 |
ALBUMIN GLOBULIN RATIO DECREASED |
1 |
0.0043 |
| 12 |
POLYCHROMASIA |
1 |
0.0033 |
| 13 |
TRANSFERRIN SATURATION INCREASED |
1 |
0.0029 |
| 14 |
URINARY CASTS |
1 |
0.0026 |
| 15 |
VASCULAR INSUFFICIENCY |
1 |
0.0026 |
| 16 |
STICKY SKIN |
1 |
0.0025 |
| 17 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 18 |
NITRITE URINE PRESENT |
1 |
0.0023 |
| 19 |
POST THROMBOTIC SYNDROME |
1 |
0.0022 |
| 20 |
TINEA CRURIS |
1 |
0.0020 |
| 21 |
CSF TEST ABNORMAL |
1 |
0.0020 |
| 22 |
POSTURING |
1 |
0.0019 |
| 23 |
EOSINOPHIL PERCENTAGE INCREASED |
1 |
0.0018 |
| 24 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 25 |
PERFUME SENSITIVITY |
1 |
0.0018 |
| 26 |
OPEN ANGLE GLAUCOMA |
1 |
0.0016 |
| 27 |
URINARY SEDIMENT PRESENT |
1 |
0.0016 |
| 28 |
VULVAL DISORDER |
1 |
0.0015 |
| 29 |
PAINFUL ERECTION |
1 |
0.0015 |
| 30 |
URINE LEUKOCYTE ESTERASE POSITIVE |
1 |
0.0014 |
| 31 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 32 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 33 |
HAPTOGLOBIN DECREASED |
1 |
0.0012 |
| 34 |
RETICULOCYTE COUNT INCREASED |
1 |
0.0012 |
| 35 |
MEAN PLATELET VOLUME DECREASED |
1 |
0.0012 |
| 36 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 37 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 38 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 39 |
STEROID WITHDRAWAL SYNDROME |
1 |
0.0010 |
| 40 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 41 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 42 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 43 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 44 |
NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0008 |
| 45 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 46 |
LIP EXFOLIATION |
1 |
0.0008 |
| 47 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 48 |
VULVOVAGINAL CANDIDIASIS |
1 |
0.0007 |
| 49 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 50 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 51 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 52 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 53 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 54 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 55 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 56 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 57 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 58 |
MIDDLE EAR EFFUSION |
1 |
0.0005 |
| 59 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 60 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 61 |
RADICULOPATHY |
1 |
0.0004 |
| 62 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 63 |
APPLICATION SITE PAIN |
8 |
0.0004 |
| 64 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
2 |
0.0004 |
| 65 |
PRODUCT CONTAINER ISSUE |
3 |
0.0003 |
| 66 |
PARAPLEGIA |
1 |
0.0003 |
| 67 |
HAEMOTHORAX |
1 |
0.0003 |
| 68 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 69 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 70 |
PENILE PAIN |
1 |
0.0003 |
| 71 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 72 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 73 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 74 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 75 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 76 |
CERVIX CARCINOMA |
1 |
0.0003 |
| 77 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 78 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 79 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 80 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 81 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 82 |
VAGINAL INFECTION |
1 |
0.0002 |
| 83 |
SKIN ABRASION |
1 |
0.0002 |
| 84 |
VULVOVAGINAL PAIN |
1 |
0.0002 |
| 85 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 86 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 87 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 88 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 89 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 90 |
CHEILITIS |
1 |
0.0002 |
| 91 |
APPLICATION SITE PRURITUS |
4 |
0.0002 |
| 92 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 93 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 94 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 95 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 96 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 97 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 98 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 99 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 100 |
BREAST TENDERNESS |
1 |
0.0001 |
| 101 |
HAEMOLYSIS |
1 |
0.0001 |
| 102 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 103 |
DECUBITUS ULCER |
1 |
0.0001 |
| 104 |
PYELONEPHRITIS |
1 |
0.0001 |
| 105 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 106 |
GROIN PAIN |
1 |
0.0001 |
| 107 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 108 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 109 |
LIP DRY |
1 |
0.0001 |
| 110 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0001 |
| 111 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 112 |
AFFECT LABILITY |
1 |
0.0001 |
| 113 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 114 |
KIDNEY INFECTION |
2 |
0.0001 |
| 115 |
OVARIAN CYST |
1 |
0.0001 |
| 116 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 117 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 118 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 119 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 120 |
SKIN LACERATION |
1 |
0.0001 |
| 121 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 122 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 123 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 124 |
EXPIRED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 125 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 126 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 127 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 128 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 129 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 130 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 131 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 132 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 133 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 134 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 135 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 136 |
OSTEOPENIA |
1 |
0.0001 |
| 137 |
LYMPHOMA |
1 |
0.0001 |
| 138 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 139 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 140 |
FUNGAL INFECTION |
2 |
0.0001 |
| 141 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 142 |
BURNING SENSATION |
4 |
0.0001 |
| 143 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 144 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 145 |
TOOTHACHE |
1 |
0.0001 |
| 146 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 147 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 148 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 149 |
SKIN FISSURES |
1 |
0.0001 |
| 150 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 151 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 152 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 153 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 154 |
DERMATITIS |
1 |
0.0000 |
| 155 |
SKIN CANCER |
1 |
0.0000 |
| 156 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 157 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 158 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 159 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 160 |
CHROMATURIA |
1 |
0.0000 |
| 161 |
SKIN IRRITATION |
2 |
0.0000 |
| 162 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 163 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 164 |
NEURALGIA |
1 |
0.0000 |
| 165 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 166 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 167 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 168 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 169 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 170 |
LIMB INJURY |
1 |
0.0000 |
| 171 |
WOUND |
1 |
0.0000 |
| 172 |
PAIN IN JAW |
1 |
0.0000 |
| 173 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 174 |
EYE IRRITATION |
2 |
0.0000 |
| 175 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 176 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 177 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 178 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 179 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 180 |
CYSTITIS |
1 |
0.0000 |
| 181 |
SWELLING FACE |
2 |
0.0000 |
| 182 |
SKIN DISORDER |
1 |
0.0000 |
| 183 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 184 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 185 |
DELIRIUM |
1 |
0.0000 |
| 186 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 187 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 188 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 189 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 190 |
DYSGEUSIA |
2 |
0.0000 |
| 191 |
DYSARTHRIA |
1 |
0.0000 |
| 192 |
JOINT SWELLING |
3 |
0.0000 |
| 193 |
OSTEOPOROSIS |
1 |
0.0000 |
| 194 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 195 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 196 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 197 |
HYPOACUSIS |
1 |
0.0000 |
| 198 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 199 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 200 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 201 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 202 |
HYPOKALAEMIA |
1 |
0.0000 |
| 203 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 204 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 205 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 206 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 207 |
PRURITUS |
8 |
0.0000 |
| 208 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 209 |
INFLAMMATION |
1 |
0.0000 |
| 210 |
ECZEMA |
1 |
0.0000 |
| 211 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 212 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 213 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 214 |
MEDICATION ERROR |
1 |
0.0000 |
| 215 |
HYPONATRAEMIA |
1 |
0.0000 |
| 216 |
EYE PAIN |
1 |
0.0000 |
| 217 |
FLATULENCE |
1 |
0.0000 |
| 218 |
DRUG INEFFECTIVE |
23 |
0.0000 |
| 219 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 220 |
DYSPHONIA |
1 |
0.0000 |
| 221 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 222 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 223 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 224 |
DRY SKIN |
2 |
0.0000 |
| 225 |
WEIGHT DECREASED |
4 |
0.0000 |
| 226 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 227 |
AGITATION |
1 |
0.0000 |
| 228 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 229 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 230 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 231 |
RASH |
5 |
0.0000 |
| 232 |
INSOMNIA |
3 |
0.0000 |
| 233 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 234 |
MUSCLE SPASMS |
2 |
0.0000 |
| 235 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 236 |
CHEST PAIN |
2 |
0.0000 |
| 237 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 238 |
DYSPHAGIA |
1 |
0.0000 |
| 239 |
MIGRAINE |
1 |
0.0000 |
| 240 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 241 |
SYNCOPE |
1 |
0.0000 |
| 242 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 243 |
SINUSITIS |
1 |
0.0000 |
| 244 |
ERYTHEMA |
2 |
0.0000 |
| 245 |
ILLNESS |
1 |
0.0000 |
| 246 |
HAEMORRHAGE |
1 |
0.0000 |
| 247 |
INFLUENZA |
1 |
0.0000 |
| 248 |
DEPRESSION |
2 |
0.0000 |
| 249 |
CHILLS |
1 |
0.0000 |
| 250 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 251 |
PAIN |
5 |
0.0000 |
| 252 |
RENAL FAILURE |
1 |
0.0000 |
| 253 |
VISION BLURRED |
1 |
0.0000 |
| 254 |
INFECTION |
1 |
0.0000 |
| 255 |
HYPOAESTHESIA |
1 |
0.0000 |
| 256 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 257 |
VOMITING |
3 |
0.0000 |
| 258 |
DRUG INTERACTION |
1 |
0.0000 |
| 259 |
DIARRHOEA |
4 |
0.0000 |
| 260 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 261 |
TREMOR |
1 |
0.0000 |
| 262 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 263 |
OFF LABEL USE |
5 |
0.0000 |
| 264 |
COVID-19 |
1 |
0.0000 |
| 265 |
ANAEMIA |
1 |
0.0000 |
| 266 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 267 |
FATIGUE |
4 |
0.0000 |
| 268 |
NAUSEA |
4 |
0.0000 |
| 269 |
HEADACHE |
3 |
0.0000 |
| 270 |
CONSTIPATION |
1 |
0.0000 |
| 271 |
MALAISE |
2 |
0.0000 |
| 272 |
WEIGHT INCREASED |
1 |
0.0000 |
| 273 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 274 |
BACK PAIN |
1 |
0.0000 |
| 275 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 276 |
FEELING ABNORMAL |
1 |
0.0000 |
| 277 |
DIZZINESS |
2 |
0.0000 |
| 278 |
PNEUMONIA |
1 |
0.0000 |
| 279 |
PYREXIA |
1 |
0.0000 |
| 280 |
ASTHENIA |
1 |
0.0000 |
| 281 |
DYSPNOEA |
1 |
0.0000 |